Wegovy
- Semaglutide lowers body weight with greater fat mass loss than lean mass loss.
Label revised Jun 18, 2026. DailyMed
Wegovy, Zepbound and Foundayo say the weight lost is more fat than lean mass, which also means some lean mass is lost. The other labels do not say.
Read from each manufacturer's FDA label on DailyMed. The newest revision saying anything on this is Aug 28, 2026.
Sentences from each label, in its own words. Only cross-references are removed.
Label revised Jun 18, 2026. DailyMed
Label revised Aug 28, 2026. DailyMed
Label revised Jul 29, 2026. DailyMed
Ozempic, Rybelsus and Ozempic tablets, Mounjaro, Trulicity, Saxenda, Victoza, Byetta: no finding on this in the sections read here.
Written from each source's own record as it changes. Every change on GLPcompare
Its FDA label: Semaglutide lowers body weight with greater fat mass loss than lean mass loss.
Its FDA label: Tirzepatide lowers body weight with greater fat mass loss than lean mass loss.
Its FDA label: Foundayo reduces body weight, with greater fat mass loss than lean mass loss.
Trial rates describe groups, not what one person will feel. Talk to your clinician before starting, stopping or changing a medicine.